Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000711377-25-000073
Filing Date
2025-11-04
Accepted
2025-11-04 08:56:08
Documents
1
Period of Report
2025-11-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1486
  Complete submission text file 0000711377-25-000073.txt   2872
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Issuer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116
Business Address
Riggsbee Richard Bryan (Reporting) CIK: 0001621899 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-17988 | Film No.: 251446743